Patent · US Active

Process for the preparation of dasatinib and its intermediates

US9365526B2 · kind B2 · utility

6Cited by
4References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 31, 2013
Grant dateJun 14, 2016
Priority date
Expiry dateDec 31, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to processes for the preparation of dasatinib and its intermediates.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.